北京热景生物技术股份有限公司关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告

Core Points - The company, Beijing Hotgen Biotech Co., Ltd., has announced a share repurchase plan approved by its board of directors on November 11, 2025 [1][2] - The announcement includes details about the top ten shareholders and the top ten unrestricted shareholders as of the day before the board meeting [1] Group 1: Share Repurchase Plan - The board of directors approved a share repurchase plan via centralized bidding [1] - The details of the repurchase plan were disclosed on November 12, 2025, on the Shanghai Stock Exchange and other designated media [1] Group 2: Shareholder Information - The announcement includes the names, shareholdings, and ownership percentages of the top ten shareholders [1] - It also provides information on the top ten unrestricted shareholders, although specific data is not detailed in the announcement [1]